Traws Pharma, Inc. (TRAW) AI Dilution Summary

TRAW reported cash of $5,016,000 at 2026-06-30 against estimated monthly burn of $1,680,000, funding itself through an active ATM with Citizens JMP Securities, LLC, authorised to $50,000,000. Its most recent capital raised is ATM sales through 2026-06-30, 1,193,513 shares since the program began; sales after 2026-06-30 are not yet reported.